TNDM
Tandem Diabetes Care IncCompany with tickers: TNDM
CIK
1438133
CUSIP
875372203
Shares Outstanding
68,529,089
Website
https://www.tandemdiabetes.com
13F Activity (30d)
14 filings
11 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $247,221,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $136,788,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $154,222,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | — | ||||
| Operating Income | $-17,434,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-20,393,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.30 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.30 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| United States | $588,765,000 | $554,878,000 | $672,685,000 | $706,936,000 |
| Non Us | $212,452,000 | $192,840,000 | $267,518,000 | $307,800,000 |
By Product & Service (USD)
| Component | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Supplies And Other | $372,859,000 | $406,983,000 | $475,785,000 | $550,597,000 |
| Pump | $431,907,000 | $365,842,000 | $434,169,000 | $464,139,000 |
| Tandem Choice Program Recognized Deferred | $-3,549,000 | $-25,107,000 | $30,249,000 | $0 |